BriaCell Therapeutics Corp BriaCell (NASDAQ: BCTX) Announces Launch of Repurchase Program BriaCell Therapeutics Corp. (NASDAQ: BCTX) has disclosed that it has decided to launch the repurchase program of the firm. The buyback program also includes the acquisition of more than 411,962 publicly traded BCTXW warrants in total.
Benitec Biopharma Inc Benitec (NASDAQ: BNTC) to Raise $12.9M from Offering of Common Stock Benitec Biopharma Inc. (NASDAQ: BNTC) declared that it has decided to increase the earlier announced offering and buying of 3,036,366 shares of common stock of the firm.
Cardlytics Inc Cardlytics (NASDAQ: CDLX) Declares Pricing Of Public Offering Of Common Stock Cardlytics, Inc. (NASDAQ: CDLX) declared the pricing of an underwritten public offering of 3,850,000 shares of its common stock. CDLX has set a price to the public of $130.00 per share.